Some researchers have suggested that CXCR4-overexpressing cells downregulate the expression of cyclin D1 and Bcl-2 and activate other signaling pathways such as MAPK to support cell proliferation and tumor progression [32]. The gene discussed is BCL2; the disease is neoplasm.